These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 23873013
1. Clinical value of mesothelin in pleural effusions versus histology by medical thoracoscopy: brief report. Canessa PA, Ferro P, Manta C, Sivori M, Franceschini MC, Fedeli F, Roncella S. Med Oncol; 2013; 30(3):649. PubMed ID: 23873013 [Abstract] [Full Text] [Related]
2. Diagnostic value of soluble mesothelin-related peptides in pleural effusion for malignant pleural mesothelioma: An updated meta-analysis. Gao R, Wang F, Wang Z, Wu Y, Xu L, Qin Y, Shi H, Tong Z. Medicine (Baltimore); 2019 Apr; 98(14):e14979. PubMed ID: 30946324 [Abstract] [Full Text] [Related]
3. Mesothelin is more useful in pleural effusion than in serum in the diagnosis of pleural mesothelioma. Ferro P, Canessa PA, Battolla E, Dessanti P, Franceschini MC, Chiaffi L, Morabito A, Fontana V, Pezzi R, Fedeli F, Pistillo MP, Roncella S. Anticancer Res; 2013 Jun; 33(6):2707-13. PubMed ID: 23749930 [Abstract] [Full Text] [Related]
4. Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma. Battolla E, Canessa PA, Ferro P, Franceschini MC, Fontana V, Dessanti P, Pinelli V, Morabito A, Fedeli F, Pistillo MP, Roncella S. Anticancer Res; 2017 Mar; 37(3):1387-1391. PubMed ID: 28314308 [Abstract] [Full Text] [Related]
5. Mesothelin in serum and pleural effusion in the diagnosis of malignant pleural mesothelioma with non-positive cytology. Franceschini MC, Ferro P, Canessa PA, Battolla E, Dessanti P, Valentino A, Casolari L, Fontana V, Pezzi R, Fedeli F, Pistillo MP, Roncella S. Anticancer Res; 2014 Dec; 34(12):7425-9. PubMed ID: 25503183 [Abstract] [Full Text] [Related]
6. Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center. Otoshi T, Kataoka Y, Ikegaki S, Saito E, Matsumoto H, Kaku S, Shimada M, Hirabayashi M. PLoS One; 2017 Dec; 12(10):e0185850. PubMed ID: 28968445 [Abstract] [Full Text] [Related]
7. Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology. Canessa PA, Franceschini MC, Ferro P, Battolla E, Dessanti P, Manta C, Sivori M, Pezzi R, Fontana V, Fedeli F, Pistillo MP, Roncella S. Cancer Invest; 2013 Jan; 31(1):43-50. PubMed ID: 23249166 [Abstract] [Full Text] [Related]
8. CCL2, galectin-3, and SMRP combination improves the diagnosis of mesothelioma in pleural effusions. Blanquart C, Gueugnon F, Nguyen JM, Roulois D, Cellerin L, Sagan C, Perigaud C, Scherpereel A, Gregoire M. J Thorac Oncol; 2012 May; 7(5):883-9. PubMed ID: 22729037 [Abstract] [Full Text] [Related]
9. Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma. Scherpereel A, Grigoriu B, Conti M, Gey T, Grégoire M, Copin MC, Devos P, Chahine B, Porte H, Lassalle P. Am J Respir Crit Care Med; 2006 May 15; 173(10):1155-60. PubMed ID: 16456138 [Abstract] [Full Text] [Related]
10. Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions. Pass HI, Wali A, Tang N, Ivanova A, Ivanov S, Harbut M, Carbone M, Allard J. Ann Thorac Surg; 2008 Jan 15; 85(1):265-72; discussion 272. PubMed ID: 18154821 [Abstract] [Full Text] [Related]
11. Determination of Mesothelin Levels in Pleural Effusion Does Not Help Predict Survival of Patients With Malignant Pleural Mesothelioma. Fontana V, Pistillo MP, Vigani A, Canessa PA, Berisso G, Giannoni U, Ferro P, Franceschini MC, Carosio R, Tonarelli M, Rossi C, Dessanti P, Roncella S. Anticancer Res; 2019 Sep 15; 39(9):5219-5223. PubMed ID: 31519636 [Abstract] [Full Text] [Related]
12. Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma. Yamada S, Tabata C, Tabata R, Fukuoka K, Nakano T. Clin Chem Lab Med; 2011 Oct 15; 49(10):1721-6. PubMed ID: 21692685 [Abstract] [Full Text] [Related]
13. Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions. Alemán C, Manuel Porcel J, Ma Segura R, Alegre J, Esquerda A, Ruiz E, Bielsa S, de Sevilla TF. Med Clin (Barc); 2009 Oct 03; 133(12):449-53. PubMed ID: 19783262 [Abstract] [Full Text] [Related]
14. Diagnostic value of mesothelin in pleural fluids: comparison with CYFRA 21-1 and CEA. Filiberti R, Parodi S, Libener R, Ivaldi GP, Canessa PA, Ugolini D, Bobbio B, Marroni P. Med Oncol; 2013 Jun 03; 30(2):543. PubMed ID: 23532816 [Abstract] [Full Text] [Related]
15. Markers for the non-invasive diagnosis of mesothelioma: a systematic review. van der Bij S, Schaake E, Koffijberg H, Burgers JA, de Mol BA, Moons KG. Br J Cancer; 2011 Apr 12; 104(8):1325-33. PubMed ID: 21448170 [Abstract] [Full Text] [Related]
16. Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma. Burt BM, Lee HS, Lenge De Rosen V, Hamaji M, Groth SS, Wheeler TM, Sugarbaker DJ. Ann Thorac Surg; 2017 Nov 12; 104(5):1679-1687. PubMed ID: 28964420 [Abstract] [Full Text] [Related]
17. Biomarkers for mesothelioma. Scherpereel A, Lee YC. Curr Opin Pulm Med; 2007 Jul 12; 13(4):339-443. PubMed ID: 17534183 [Abstract] [Full Text] [Related]
19. Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma. Creaney J, Dick IM, Meniawy TM, Leong SL, Leon JS, Demelker Y, Segal A, Musk AW, Lee YC, Skates SJ, Nowak AK, Robinson BW. Thorax; 2014 Oct 12; 69(10):895-902. PubMed ID: 25037982 [Abstract] [Full Text] [Related]
20. Diagnostic value of pleural fluid SMRP, CA125, MMP-7, and MMP-9 in malignant pleural effusion. Han G, Li J, Liu X, Guo R. Medicine (Baltimore); 2023 Jan 27; 102(4):e32759. PubMed ID: 36705352 [Abstract] [Full Text] [Related] Page: [Next] [New Search]